ASTERDM (Aster DM Healthcare Ltd.): Order Win
Aster DM Healthcare Ltd. has informed the exchange that it received the certified true copy of an NCLT order sanctioning a Scheme of Amalgamation, according to an NSE filing dated 24 June. The National Company Law Tribunal approval represents a formal regulatory clearance for the corporate restructuring, which the company disclosed after market hours.
Events like this — regulatory order wins for amalgamation schemes — have historically shown a 72% win rate across 50 comparable past instances, with a net edge of 1.6%, according to Strota's base-rate data. These figures reflect how similar announcements have performed on average in the past, not a forecast for this specific stock.
At the close of 23 June, the stock traded at ₹765.85, down 8.45% from its 52-week high of ₹836.5 but up 47.53% from its 52-week low of ₹519.1. The 14-day RSI stood at 50.0, indicating neutral momentum, while relative volume at 1.25 showed slightly elevated trading interest. The shares have returned 22.15% over three months and 34.43% over one year. The company commands a market capitalisation of ₹39,789 crore, with a price-to-earnings ratio of 119.7 and return on equity of 10.1%.
The filing confirms the NCLT sanction has been obtained; it does not establish whether the amalgamation will proceed on the original terms, the timeline for implementation, or any financial impact on consolidated operations. Investors would need to monitor subsequent filings for the effective date of the scheme and any operational disclosures.
The catalyst
Aster DM Healthcare Limited has informed the Exchange about receipt of certified true copy of the order of NCLT sanctioning Scheme of Amalgamation (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Order Win tends to continue — the move went bullish in about 72.0% of next sessions (net 1.6% after drift and cost, n=50). A base rate, not a forecast for this stock.
ASTERDM right now
trading +0.50% on the day; P/E 119.7; RSI 50.0. Full ASTERDM analysis →
Sources
- Aster DM Healthcare Limited has informed the Exchange about receipt of certified true copy of the order of NCLT sanctioning Scheme of Amalgamation — NSE
- Aster DM Healthcare Ltd subsidiary allots CCPS to investors via private placement — scanx.trade
- Aurobindo Pharma Ltd leads losers in 'A' group — Business Standard
- Number of shareholders of Aster DM Healthcare Ltd. – NSE:ASTERDM — TradingView
- How The Aster DM Healthcare (NSEI:ASTERDM) Narrative Is Shifting With New Valuation Assumptions — Simply Wall St.
Keep digging
- ASTERDM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.